"Having a one-stop-shop vendor that is able to cover all the aspects of any project, at any...
Global Full Service CRO with an Integrated Clinical Supply Chain
We provide our customers with a comprehensive range of worldwide & end-to-end solutions for clinical trials throughout the entire life cycle of the study. Adapting to the needs of the sponsor, SanaClis is able to work both as a full and functional service provider.
Founded in 2000 by renowned industry leaders, SanaClis was one of the very first Supply Chain and CRO providers in many countries across Europe. Over the last 20+ years in order to meet the evolving needs of our customers, SanaClis significantly expanded its global footprint, covering all of Europe, North America, LATAM, APAC and South Africa.
We have successfully delivered on a diverse array of projects entrusted into our care by various size sponsors, ranging from virtual biotech's through to top 10 pharmaceutical companies. Over 93% of clinical studies within our care were completed on or ahead of schedule and on budget.
SanaClis provides a comprehensive range CRO and Clinical Supply Chain services across all therapeutic areas and phases and in all major geographic locations. We provide our customers with added value options, through our substantial and unique experience in Central and Eastern European countries which typically offer an abundance of advantages, from high patient enrollment rates through to high quality data. Our ability to offer a flexible Full Service or Functional service model provides the flexibility demanded by the project but also provides the potential to streamline the entire study.
In addition, SanaClis has a portfolio of privately owned GMP and GDP certified storage and distribution depots strategically located worldwide including a qualified depot network.
Our People are at the Heart of Everything We Do
As CEO, Alexander Fetkovsky has overall responsibility for the planning and execution of strategic company initiatives and business partnering, in addition to global operational and financial oversight for multiple clinical programs and clinical trial supply/warehouse operations. He previously held several C-level positions such as Senior Managing Partner and Member of the Board.
Roman Hrynchuk is responsible for all SanaClis operational units including Clinical Operations, Clinical Trial Supply Chain, Pharmacovigilance, Medical Affairs and Sourcing. With over 15 years of experience in the pharmaceutical business, Roman leverages a profound knowledge of clinical research and a passion for operations, to continuously improve the company’s performance, while retaining compliance with regulatory requirements and best practices.
VP Global Business Development & Country Head Germany
Sascha Sonnenberg is a subject matter expert of a broad range of services along the clinical supply chain such as Direct-to-Patient, labelling & packaging, cell & gene therapies, and global distribution strategies. He has been a long-term member of the ISPE Investigational Product community, contributed to the development of several Good Practice Guides and was a member of the European IP Steering Committee.
VP Clinical Operations
Maria Tomkova has 20 years of experience in the biopharma product development field and the biotech industry. She has a proven track record as a Head of Clinical Development Division for Global Clinical Operations as well as a Managing Director of a local subsidiary of a global corporation. Maria has vast experience in managing Clinical Operations, Regulatory & Site Start Up, as well as Project Management at an international and regional level.
VP Clinical Supply Chain Operations
Marian Kulich has more than 25 years of experience in the pharmaceutical industry. He has held various senior roles in pharmacology and pharmacy, he has experience working in a pharmaceutical wholesaler, at global pharma-companies as well as in private businesses focused on pharmaceutical production, market access and regulatory affairs. Marian is also a member of the ECA QP Association, Reg. No:251267
VP Global Business Development & Country Head UK
John Murray leverages his profound experience within the drug development sphere across multiple disciplines, from clinical operations, supply chain, sourcing and risk mitigation co-investment. John is brokering new strategic partnerships and developing existing collaborations between SanaClis and top 10 Pharma through to single asset biotechs. He currently heads high-priority alliances with various global governmental institutions.
Be Part of a Team Where You Can Learn, Grow and Thrive!
Our company culture offers great opportunities for career growth where you can develop your potential within an international environment. Throughout your career, at SanaClis you will have multiple opportunities in a variety of projects and exposure to a range of therapeutic areas.
End-to-end Clinical Operational provider with a vast experience in successfully conducting clinical trial projects for various sized sponsors, ranging from virtual biotech’s through to top ten pharma companies.
Clinical Supply Chain Services
Clinical Supply Chain Services
End-to-end GMP Clinical Supply Chain services, including Global Sourcing (of any marketed product and or ancillaries). We support your supply chain needs globally, across all major regions.
Functional & Full-Service Model
Functional & Full-Service Model
We support your study entirely or functionally, based upon the study and sponsors needs. SanaClis provides unrivaled end-to-end services to ensure study success, on time and on budget.
SanaClis: Transforming the Healthcare Industry with End-to-End Clinical Services
Updated: October 7, 2021
SanaClis provides a streamlined end-to-end clinical service to the customers through the entire lifecycle of the clinical project allowing for operational and financial efficiencies, which proved to be and still is, a huge attraction for the customers, who have enjoyed the benefits of this approach for years, across multiple clinical projects.
Integrating a Personal Approach to Clinical Supply Services
Updated: September 14, 2021
Alexander Fetkovsky: I truly believe in taking a traditional approach and creating a culture based on personal involvement — whether it’s the doctor or CRA. SanaClis does a lot of remote monitoring visits, but, in every situation, we maintain a hands-on approach. I expect this to be true as the industry continues to transform into a virtual ecosystem.
January 17, 2023 SanaClis is proud to announce a high-level sponsorship deal for the rising...
At the end of last year (2022), SanaClis’ CEO Alexander Fetkovsky signed a cooperation...